Vinge advises M42 on its acquisition of Diaverum from Bridgepoint

May 22, 2023 M&A

Vinge is advising M42, an Abu Dhabi-based tech-enabled healthcare company in connection with is acquisition of Diaverum AB.

M42 is a global tech-enabled healthcare leader operating at the forefront of medical development. Diaverum is currently the world’s third-largest provider of dialysis services, operating across 23 countries, with 440 clinics and over 13,000 employees. The acquisition of Diaverum significantly expands M42’s global geographic footprint, enabling it to introduce relevant healthcare services and healthtech solutions in new markets while further enhancing its renal care offering in the GCC. The transaction, which is subject to customary regulatory approvals, is expected to close later in 2023.

Vinges team consisted of Matthias Pannier, Stina Bengtsson, Christoffer Nordin, Josefin Lanker och Josef Groow.



Vinge advises Stride.VC in connection with its investment in Anotherblock

In 2022, Anotherblock launched a blockchain-based marketplace for music rights. The company has through its platform granted fans access to streaming rights from several known artists. The investment round is led by Stride.VC.
May 25, 2023

Vinge advises Tele2 in connection with its notes issuance and tender offer

Vinge advises Tele2 AB (publ) in connection with its issuance of senior unsecured fixed rate notes in an amount of EUR 500 million and its parallel tender offer in respect of its previously issued notes due 2024.
May 22, 2023

Vinge advises IBT in connection with rights offering

Vinge advises Infant Bacterial Therapeutics AB (publ) in connection with its rights offering of approximately SEK 100 million.
May 19, 2023